Today’s pharma and biotech professionals are challenged with making sense of the overwhelming volume of clinical trial and RWE data used to develop products in order to meet accelerated commercial demands. However, the ability to generate robust, actionable data insights quickly and confidently is often beyond even the most experienced team’s scope.

Doctor Evidence and studioID invite you to hear from accomplished senior experts in the industry, publishing and academia as they debate the important questions facing biopharma today and reveal solutions to help you accelerate key decision-making processes and improve clinical and commercial performance. The panel discussion will include:

  • Industry changes and challenges of the last few years
  • Technology’s role in the conduct of literature reviews and analytics
  • The appropriate roles of systematic reviews and rapid reviews
  • Technology and analytics solutions that can help advance product development and lifecycle management